SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 3.57 |
Enterprise Value ($M) | 2.38 |
Book Value ($M) | 1.70 |
Book Value / Share | 1.41 |
Price / Book | 2.09 |
NCAV ($M) | 1.60 |
NCAV / Share | 1.32 |
Price / NCAV | 2.23 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.30 |
Return on Assets (ROA) | -1.46 |
Return on Equity (ROE) | -1.86 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.33 |
Current Ratio | 4.33 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2.08 |
Assets | 2.18 |
Liabilities | 0.48 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Kaufman Jonathan H | 16.20 | 5.60 | |
13D/A | Chancellor Michael B | 16.00 | 0.00 | |
13G/A | Gruber Michele | 5.50 | 3.30 | |
13G/A | Huang Leaf | 9.60 | 0.00 | |
13G | Sabby Management, Llc | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
19,057 | 95,274 | 20.00 | |
25,155 | 101,745 | 24.72 | |
106,207 | 273,626 | 38.81 | |
309,220 | 944,560 | 32.74 | |
(click for more detail) |
Similar Companies | |
---|---|
LEXX – Lexaria Bioscience Corp. | LFVN – LifeVantage Corporation |
LGVN – Longeveron Inc. | LIXT – Lixte Biotechnology Holdings, Inc. |
LPCN – Lipocine Inc. |
Financial data and stock pages provided by
Fintel.io